Eisai Inc.
Eisai Inc. lists 28 drug products in the FDA National Drug Code directory.
Products
| NDC | Product | Strength | Type |
|---|---|---|---|
| 62856-245 | Aricept Tablet, Film Coated | Donepezil Hydrochloride 5 mg/1 | Rx |
| 62856-246 | Aricept Tablet, Film Coated | Donepezil Hydrochloride 10 mg/1 | Rx |
| 62856-247 | Aricept Tablet, Film Coated | Donepezil Hydrochloride 23 mg/1 | Rx |
| 62856-584 | Banzel Suspension | Rufinamide 40 mg/mL | Rx |
| 62856-583 | Banzel Tablet, Film Coated | Rufinamide 400 mg/1 | Rx |
| 62856-582 | Banzel Tablet, Film Coated | Rufinamide 200 mg/1 | Rx |
| 62856-410 | Dayvigo Tablet, Film Coated | Lemborexant 10 mg/1 | Rx |
| 62856-405 | Dayvigo Tablet, Film Coated | Lemborexant 5 mg/1 | Rx |
| 62856-278 | Fycompa Tablet | Perampanel 8 mg/1 | Rx |
| 62856-290 | Fycompa Suspension | Perampanel .5 mg/mL | Rx |
| 62856-282 | Fycompa Tablet | Perampanel 12 mg/1 | Rx |
| 62856-280 | Fycompa Tablet | Perampanel 10 mg/1 | Rx |
| 62856-276 | Fycompa Tablet | Perampanel 6 mg/1 | Rx |
| 62856-274 | Fycompa Tablet | Perampanel 4 mg/1 | Rx |
| 62856-272 | Fycompa Tablet | Perampanel 2 mg/1 | Rx |
| 62856-389 | Halaven Injection | Eribulin Mesylate .5 mg/mL | Rx |
| 62856-222 | Lecanemab Autoinjector Injection, Solution | Lecanemab-irmb 200 mg/mL | Rx |
| 62856-220 | Lecanemab Autoinjector Injection, Solution | Lecanemab-irmb 200 mg/mL | Rx |
| 62856-714 | Lenvima Kit | Rx | |
| 62856-712 | Lenvima Capsule | Lenvatinib 4 mg/1 | Rx |
| 62856-724 | Lenvima Kit | Rx | |
| 62856-718 | Lenvima Kit | Rx | |
| 62856-720 | Lenvima Capsule | Lenvatinib 10 mg/1 | Rx |
| 62856-710 | Lenvima Capsule | Lenvatinib 10 mg/1 | Rx |
| 62856-708 | Lenvima Capsule | Lenvatinib 4 mg/1 | Rx |
| 62856-704 | Lenvima Capsule | Lenvatinib 4 mg/1 | Rx |
| 62856-215 | Leqembi Injection, Solution | Lecanemab 100 mg/mL | Rx |
| 62856-212 | Leqembi Injection, Solution | Lecanemab 100 mg/mL | Rx |